Invention Grant
- Patent Title: Analytical ultracentrifugation for characterization of recombinant viral particles
-
Application No.: US16547144Application Date: 2019-08-21
-
Publication No.: US11639887B2Publication Date: 2023-05-02
- Inventor: Catherine R. O'Riordan , Brenda Burnham
- Applicant: Genzyme Corporation
- Applicant Address: US MA Cambridge
- Assignee: Genzyme Corporation
- Current Assignee: Genzyme Corporation
- Current Assignee Address: US MA Cambridge
- Agency: Morrison & Foerster LLP
- Main IPC: G01N15/04
- IPC: G01N15/04 ; C12N7/00 ; G01N1/40

Abstract:
Provided herein are methods to characterize preparations of recombinant viral particles using analytical ultracentrifugation. Recombinant viral particles include recombinant adeno-associated viral particles, recombinant adenoviral particles, recombinant lentiviral particles and recombinant herpes simplex virus particles. Variant species of recombinant viral particles including empty capsids and recombinant viral particles with variant genomes (e.g., truncated genomes, aggregates, recombinants) can be identified and quantitated. The methods can be used to characterize preparations of recombinant viral particles regardless of the sequence of the recombinant viral genome or the serotype of the recombinant viral capsid.
Public/Granted literature
- US20200225139A1 ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT VIRAL PARTICLES Public/Granted day:2020-07-16
Information query